Publications

Title

Author

Year

Impact and cost-effectiveness of the 6-month BPaLM regimen for rifampicin-resistant tuberculosis in Moldova: A mathematical modeling analysis.

James, LP; Klaassen, F; SWEENEY, S; Furin, J; Franke, MF; Yaesoubi, R; Chesov, D; Ciobanu, N; Codreanu, A; Crudu, V; Cohen, T; Menzies, NA;

2024

PLoS medicine, (2024).21 5 10.1371/journal.pmed.1004401.

Contribution of vaccination to improved survival and health: modelling 50 years of the Expanded Programme on Immunization.

Shattock, AJ; JOHNSON, HC; Sim, SY; Carter, A; Lambach, P; Hutubessy, RC W; Thompson, KM; Badizadegan, K; Lambert, B; Ferrari, MJ; JIT, M; FU, H; Silal, SP; Hounsell, RA; WHITE, RG; Mosser, JF; Gaythorpe, KA M; Trotter, CL; Lindstrand, A; O'Brien, KL; Bar-Zeev, N;

2024

Lancet (London, England), (2024).403 10441 10.1016/S0140-6736(24)00850-X.

Integrating molecular and radiological screening tools during community-based active case-finding for tuberculosis and COVID-19 in southern Africa.

Scott, AJ; Limbada, M; Perumal, T; Jaumdally, S; Kotze, A; Van der Merwe, C; Cheeba, M; Milimo, D; Murphy, K; Van Ginneken, B; De Kock, M; Warren, RM; Gina, P; Swanepoel, J; Kühn, L; Oelofse, S; Pooran, A; Esmail, A; AYLES, H; DHEDA, K;

2024

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, (2024).145, 10.1016/j.ijid.2024.107081.

Bridging the gap: evaluating high TB burden country data needs to support the potential introduction of TB vaccines for adolescents and adults: a workshop report.

CLARK, RA; Young, C; Palmer, S; Auma, E; Malhotra, S; Limaye, R; Giersing, B; Schrager, L; Voss, G; Tiemersma, E; Frick, M; Edoka, I; Dagnew, AF; Nkhoma, T; TB Vaccine Country Data Needs Group,; Pelzer, PT; WHITE, RG;

2024

Frontiers in Tuberculosis, (2024).2, 10.3389/ftubr.2024.1384036.

Catastrophic costs for tuberculosis patients in India: Impact of methodological choices.

Chatterjee, S; Das, P; Stallworthy, G; Bhambure, G; Munje, R; VASSALL, A;

2024

PLOS global public health, (2024).4 4 10.1371/journal.pgph.0003078.

Age and sex influence antibody profiles associated with tuberculosis progression.

Davies, LR L; Wang, C; Steigler, P; Bowman, KA; Fischinger, S; Hatherill, M; Fisher, M; Mbandi, SK; Rodo, M; Ottenhoff, TH M; DOCKRELL, HM; SUTHERLAND, JS; Mayanja-Kizza, H; Boom, WH; Walzl, G; Kaufmann, SH E; Nemes, E; Scriba, TJ; Lauffenburger, D; Alter, G; Fortune, SM;

2024

Nature microbiology, (2024).9 6 10.1038/s41564-024-01678-x.

The Full Value of Vaccine Assessments Concept-Current Opportunities and Recommendations.

WHITE, RG; Menzies, NA; Portnoy, A; CLARK, RA; Toscano, CM; Weller, C; Tufet Bayona, M; Silal, SP; Karron, RA; Lee, J-S; Excler, J-L; Lauer, JA; Giersing, B; Lambach, P; Hutubessy, R; JIT, M;

2024

Vaccines, (2024).12 4 10.3390/vaccines12040435.

Post-tuberculosis respiratory impairment in Gambian children and adolescents: A cross-sectional analysis.

NKEREUWEM, E; AGBLA, S; Njai, B; EDEM, VF; Jatta, ML; Owolabi, O; Masterton, U; Jah, F; Danso, M; Fofana, AN; Samateh, W; Darboe, ML; OWUSU, SA; Bush, A; KAMPMANN, B; TOGUN, T;

2024

Pediatric pulmonology, (2024).59 7 10.1002/ppul.27009.

Impact of the COVID-19 pandemic on the real-world diagnostic infrastructure for tuberculosis-An ESGMYC collaborative study.

Paulowski, L; Filip, R; Jankovic Makek, M; Guglielmetti, L; Goletti, D; Van Ingen, J; KRANZER, K; Maurer, FP; ESGMYC,;

2024

PloS One, (2024).19 4 10.1371/journal.pone.0291404.

Mathematical models of drug-resistant tuberculosis lack bacterial heterogeneity: A systematic review.

FULLER, NM; MCQUAID, CF; HARKER, MJ; Weerasuriya, CK; McHugh, TD; KNIGHT, GM;

2024

PLoS pathogens, (2024).20 4 10.1371/journal.ppat.1011574.